BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30759284)

  • 1. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.
    Hou Y; Pinheiro J; Sahm F; Reuss DE; Schrimpf D; Stichel D; Casalini B; Koelsche C; Sievers P; Wefers AK; Reinhardt A; Ebrahimi A; Fernández-Klett F; Pusch S; Meier J; Schweizer L; Paulus W; Prinz M; Hartmann C; Plate KH; Reifenberger G; Pietsch T; Varlet P; Pagès M; Schüller U; Scheie D; de Stricker K; Frank S; Hench J; Pollo B; Brandner S; Unterberg A; Pfister SM; Jones DTW; Korshunov A; Wick W; Capper D; Blümcke I; von Deimling A; Bertero L
    Acta Neuropathol; 2019 May; 137(5):837-846. PubMed ID: 30759284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC44A1-PRKCA fusion in papillary and rosette-forming glioneuronal tumors.
    Nagaishi M; Nobusawa S; Matsumura N; Kono F; Ishiuchi S; Abe T; Ebato M; Wang Y; Hyodo A; Yokoo H; Nakazato Y
    J Clin Neurosci; 2016 Jan; 23():73-75. PubMed ID: 26260115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion.
    Pages M; Lacroix L; Tauziede-Espariat A; Castel D; Daudigeos-Dubus E; Ridola V; Gilles S; Fina F; Andreiuolo F; Polivka M; Lechapt-Zalcman E; Puget S; Boddaert N; Liu XQ; Bridge JA; Grill J; Chretien F; Varlet P
    Acta Neuropathol Commun; 2015 Dec; 3():85. PubMed ID: 26671581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor.
    Bridge JA; Liu XQ; Sumegi J; Nelson M; Reyes C; Bruch LA; Rosenblum M; Puccioni MJ; Bowdino BS; McComb RD
    Brain Pathol; 2013 Mar; 23(2):121-8. PubMed ID: 22725730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity.
    Siegfried A; Rousseau A; Maurage CA; Pericart S; Nicaise Y; Escudie F; Grand D; Delrieu A; Gomez-Brouchet A; Le Guellec S; Franchet C; Boetto S; Vinchon M; Sol JC; Roux FE; Rigau V; Bertozzi AI; Jones DTW; Figarella-Branger D; Uro-Coste E
    Brain Pathol; 2019 Jan; 29(1):53-62. PubMed ID: 29679497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
    Alhalabi KT; Stichel D; Sievers P; Peterziel H; Sommerkamp AC; Sturm D; Wittmann A; Sill M; Jäger N; Beck P; Pajtler KW; Snuderl M; Jour G; Delorenzo M; Martin AM; Levy A; Dalvi N; Hansford JR; Gottardo NG; Uro-Coste E; Maurage CA; Godfraind C; Vandenbos F; Pietsch T; Kramm C; Filippidou M; Kattamis A; Jones C; Øra I; Mikkelsen TS; Zapotocky M; Sumerauer D; Scheie D; McCabe M; Wesseling P; Tops BBJ; Kranendonk MEG; Karajannis MA; Bouvier N; Papaemmanuil E; Dohmen H; Acker T; von Hoff K; Schmid S; Miele E; Filipski K; Kitanovski L; Krskova L; Gojo J; Haberler C; Alvaro F; Ecker J; Selt F; Milde T; Witt O; Oehme I; Kool M; von Deimling A; Korshunov A; Pfister SM; Sahm F; Jones DTW
    Acta Neuropathol; 2021 Nov; 142(5):841-857. PubMed ID: 34417833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade developmental and epilepsy associated brain tumors: a critical update 2020.
    Slegers RJ; Blumcke I
    Acta Neuropathol Commun; 2020 Mar; 8(1):27. PubMed ID: 32151273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An individual patient data meta-analysis on characteristics and outcome of patients with papillary glioneuronal tumor, rosette glioneuronal tumor with neuropil-like islands and rosette forming glioneuronal tumor of the fourth ventricle.
    Schlamann A; von Bueren AO; Hagel C; Zwiener I; Seidel C; Kortmann RD; Müller K
    PLoS One; 2014; 9(7):e101211. PubMed ID: 24991807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
    Bogumil H; Sill M; Schrimpf D; Ismer B; Blume C; Rahmanzade R; Hinz F; Cherkezov A; Banan R; Friedel D; Reuss DE; Selt F; Ecker J; Milde T; Pajtler KW; Schittenhelm J; Hench J; Frank S; Boldt HB; Kristensen BW; Scheie D; Melchior LC; Olesen V; Sehested A; Boué DR; Abdullaev Z; Satgunaseelan L; Kurth I; Seidlitz A; White CL; Ng HK; Shi ZF; Haberler C; Deckert M; Timmer M; Goldbrunner R; Tauziède-Espariat A; Varlet P; Brandner S; Alexandrescu S; Snuderl M; Aldape K; Korshunov A; Witt O; Herold-Mende C; Unterberg A; Wick W; Pfister SM; von Deimling A; Jones DTW; Sahm F; Sievers P
    Acta Neuropathol; 2023 May; 145(5):667-680. PubMed ID: 36933012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
    Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
    Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
    Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
    Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
    Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR1 N546K mutation in a case of papillary glioneuronal tumor (PGNT).
    Gessi M; Abdel Moneim Y; Hammes J; Waha A; Pietsch T
    Acta Neuropathol; 2014; 127(6):935-6. PubMed ID: 24777483
    [No Abstract]   [Full Text] [Related]  

  • 14. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
    Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
    [No Abstract]   [Full Text] [Related]  

  • 15. Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?
    Rao S; Mitra S; Sugur H; Vazhayil V; Rao BRM; Annayappa SK; Nandeesh BN; Yasha TC; Santosh V
    Brain Tumor Pathol; 2021 Jan; 38(1):41-49. PubMed ID: 32980923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
    Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
    Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Septal dysembryoplastic neuroepithelial tumor: a comprehensive clinical, imaging, histopathologic, and molecular analysis.
    Chiang JCH; Harreld JH; Tanaka R; Li X; Wen J; Zhang C; Boué DR; Rauch TM; Boyd JT; Chen J; Corbo JC; Bouldin TW; Elton SW; Liu LL; Schofield D; Lee SC; Bouffard JP; Georgescu MM; Dossani RH; Aguiar MA; Sances RA; Saad AG; Boop FA; Qaddoumi I; Ellison DW
    Neuro Oncol; 2019 Jun; 21(6):800-808. PubMed ID: 30726976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade epilepsy-associated neuroepithelial tumours with a prominent oligodendroglioma-like component: The diagnostic challenges.
    Métais A; Appay R; Pagès M; Gallardo C; Silva K; Siegfried A; Perbet R; Maurage CA; Scavarda D; Fina F; Uro-Coste E; Riffaud L; Colin C; Figarella-Branger D;
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12769. PubMed ID: 34551121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours.
    Stone TJ; Keeley A; Virasami A; Harkness W; Tisdall M; Izquierdo Delgado E; Gutteridge A; Brooks T; Kristiansen M; Chalker J; Wilkhu L; Mifsud W; Apps J; Thom M; Hubank M; Forshew T; Cross JH; Hargrave D; Ham J; Jacques TS
    Acta Neuropathol; 2018 Jan; 135(1):115-129. PubMed ID: 29058119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions.
    Tauziède-Espariat A; Chotard G; le Loarer F; Baud J; Azmani R; Dangouloff-Ros V; Boddaert N; Icher-de-Bouyn C; Gimbert E; Hasty L; Métais A; Chrétien F; Varlet P;
    Acta Neuropathol Commun; 2022 Feb; 10(1):15. PubMed ID: 35115049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.